PROSETTA ANTIVIRAL INC has a total of 26 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are UMN PHARMA INC, ZHEJIANG ZHENYUAN PHARMACEUTICAL CO LTD and BRUNO JOHN G.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Australia | 2 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Israel | 1 | |
#8 | Japan | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Organic fine chemistry | |
#6 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Climate change adaptation technologies | |
#2 | Analysing materials | |
#3 | Microorganisms | |
#4 | Heterocyclic compounds | |
#5 | Fermentation | |
#6 | Therapeutic chemical compounds | |
#7 | Medical preparations | |
#8 | Peptides | |
#9 | Measuring microorganism processes | |
#10 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Lingappa Vishwanath R | 12 |
#2 | Atuegbu Andy | 8 |
#3 | Lingappa Vishwanath | 6 |
#4 | Hurt Clarence R | 6 |
#5 | Kitaygorodskyy Anatoliy | 5 |
#6 | Hurt Clarence | 4 |
#7 | Solas Dennis | 4 |
#8 | Freeman Beverly | 4 |
#9 | Dey Debendranath | 3 |
#10 | Paulvannan Kumar | 2 |
Publication | Filing date | Title |
---|---|---|
US2018118679A1 | N-methyl pyrazoles | |
US2016168100A1 | Anti-HIV compounds | |
US2014315897A1 | Compounds, compositions, and methods for treating alzheimer's disease | |
US2014106365A1 | Multiprotein assemblies | |
AU2012289869A1 | Cell free translation system for compound screening and related uses | |
EP2699241A1 | Antiviral compounds | |
WO2012125983A1 | Antiviral treatments | |
EP2585073A1 | Antiviral compounds |